Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Vanessa Research is now Vanessa Biotech

Hamden-based Vanessa Research is changing its name to Vanessa Biotech. The company name remains a tribute to Professor Vanessa Ameen, whose research laid the foundation...

| By Kelley Gipson

BioXcel drug named breakthrough therapy

The FDA has designated a BioXcel drug a “breakthrough therapy” for dementia-related agitation, a label that has the potential to speed up the regulatory review process. BioXcel...

| By Kelley Gipson

Pfizer site director comments on CT bill HB 6447

John Burkhardt is a Pfizer senior vice president and the director of Pfizer’s Connecticut laboratories. In a recent op-ed he writes:   We’ve enjoyed a good partnership...

| By Kelley Gipson

Oak HC/FT active in biotech investment

Since its founding in 2014, Oak HC/FT has invested in firms in health care and financial technology. A 2020 defined by the coronavirus pandemic did...

| By Kelley Gipson

SCSU hosts Virtual Bioscience Careers Forum 4/30

Companies, faculty, and students are invited to register for the Virtual Bioscience Careers Forum at Southern Connecticut State University April 30.  The theme is “Technology,...

| By Kelley Gipson

Hyperfine, Wellinks report new appointments

Hyperfine Research of Guilford reports that Dr. Khalil Salman has joined the company as its new director of clinical informatics … more New Haven startup Wellinks...

| By Kelley Gipson

Pfizer site leader cites Groton COVID-19 work

The site leader at the Pfizer labs in Groton says about 200 colleagues locally have been so focused on developing a vaccine to battle COVID-19, it’s...